These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17941035)

  • 1. New method for the simultaneous estimation of intrinsic hepatic clearance and protein binding by matrix inhibition.
    Uchimura T; Kato M; Tachibana T; Arai S; Nabuchi Y; Saito K; Kinoshita H
    Biopharm Drug Dispos; 2008 Jan; 29(1):7-16. PubMed ID: 17941035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
    Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
    Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes.
    Lu C; Li P; Gallegos R; Uttamsingh V; Xia CQ; Miwa GT; Balani SK; Gan LS
    Drug Metab Dispos; 2006 Sep; 34(9):1600-5. PubMed ID: 16790553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of microsomal concentration on apparent intrinsic clearance: implications for scaling in vitro data.
    Kalvass JC; Tess DA; Giragossian C; Linhares MC; Maurer TS
    Drug Metab Dispos; 2001 Oct; 29(10):1332-6. PubMed ID: 11560877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of quinidine on the 10-hydroxylation of R-warfarin: species differences and clearance projection.
    Chen Q; Tan E; Strauss JR; Zhang Z; Fenyk-Melody JE; Booth-Genthe C; Rushmore TH; Stearns RA; Evans DC; Baillie TA; Tang W
    J Pharmacol Exp Ther; 2004 Oct; 311(1):307-14. PubMed ID: 15163679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct determination of unbound intrinsic drug clearance in the microsomal stability assay.
    Giuliano C; Jairaj M; Zafiu CM; Laufer R
    Drug Metab Dispos; 2005 Sep; 33(9):1319-24. PubMed ID: 15951446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations.
    Jones HM; Houston JB
    Drug Metab Dispos; 2004 Sep; 32(9):973-82. PubMed ID: 15319339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
    Shibata Y; Takahashi H; Ishii Y
    Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of serum protein binding of compounds metabolized in serum using matrix inhibition.
    Uchimura T; Kato M; Shiokawa R; Nabuchi Y; Saito K; Kinoshita H
    Biopharm Drug Dispos; 2008 Jul; 29(5):308-10. PubMed ID: 18496881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
    Brown HS; Griffin M; Houston JB
    Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
    Ching MS; Morgan DJ; Smallwood RA
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1048-54. PubMed ID: 2778709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Drug Metab Dispos; 1984; 12(1):131-8. PubMed ID: 6141904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro investigation of the hepatic intrinsic clearance of apicidin, a histone deacetylase inhibitor, in mouse, rat, and human, with correction by nonspecific protein binding.
    Shin BS; Park EH; Yoon CH; Kim J; Zee O; Yoo SD
    J Toxicol Environ Health A; 2005 Dec; 68(23-24):2207-18. PubMed ID: 16326434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro investigation of the hepatic extraction of RSD1070, a novel antiarrhythmic compound.
    Tong V; Abbott FS; Mbofana S; Walker MJ
    J Pharm Pharm Sci; 2001; 4(1):15-23. PubMed ID: 11302786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.